Close Menu
Home » Cancer Researchers Detail Efforts to 'Discover, Predict, Prevent, Treat' at Opening of AACR Meeting

Cancer Researchers Detail Efforts to 'Discover, Predict, Prevent, Treat' at Opening of AACR Meeting

Apr 03, 2017
|
Christie Rizk

WASHINGTON (GenomeWeb) – The American Association for Cancer Research's annual meeting kicked off in Washington, DC, on Sunday with a tribute to past progress in research and treatment of cancer, and with some harsh words for President Donald Trump's recent proposals for deep cuts to the NIH's budget in 2017 and 2018.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Dec
17
Featured Webinar

Non-Invasive Characterization of Solid Tumors via NGS Liquid Biopsy Testing

Sponsored by
Thermo Fisher Scientific

This webinar will review how liquid biopsy can be considered as an alternative and non-invasive method to tissue biopsy for cancer molecular characterization.

Dec
19
Featured Webinar

Evolution of Tumor Profiling in a Clinical Lab: Moving toward Comprehensive Genomic Profiling

Sponsored by
Qiagen

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.  

Jan
28
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

What's Popular?

In Cancer

  1. ACMG Suggests Docs Evaluate All Breast Cancer Patients for Genetic Risk Test Suitability

  2. UK Study Details Liquid Biopsy's Ability to Guide Metastatic Breast Cancer Treatment

  3. Tempus Acquires Commercial Lab, Precision Medicine Services Provider Akesogen

  4. Universal Genetic Testing in Breast Cancer May Result in More Harm Than Good, Experts Worry

    Premium

  5. At ASH, Researchers Discuss Rapid AML Nanopore Sequencing Assay for Analyzing Actionable Alterations

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.